Clinical Correlations of Potential Activity Markers in Systemic Sclerosis-Reference-Cited by-同舟云学术

Clinical Correlations of Potential Activity Markers in Systemic Sclerosis

Published:2005-06 Issue:1 Volume:1051 Page:404-412
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

BEČVÁŘ R.,ŠTORK J.,PEŠÁKOVÁ V.,STÁŇOVÁ A.,HULEJOVÁ H.,RYSOVÁ L.,ZATLOUKALOVÁ A.,ZATLOUKAL P.,JÁCHYMOVÁ M.,POUROVÁ L.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1196/annals.1361.082/fullpdf

Reference17 articles.

1. 1Medsger, T.A. 1985. Comment on scleroderma criteria cooperative study. In Systemic sclerosis (Scleroderma). C.M. Black & A.R. Myers, Eds.: 235-249. Gower Med. New York.

2. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF beta;Xu;J. Rheumatol.,1991

3. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro;Roberts;Proc. Natl. Acad. Sci. USA,1986

4. Interleukin-2 in scleroderma: correlation of serum levels with extent of skin involvement and disease duration;Kahaleh;Ann. Intern. Med.,1989

5. 5Black, C.M., A. McWhirter, N.K. Harrison, et al. Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease duration. Br. J. Rheumatol. 28: 98-103.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension;Frontiers in Immunology;2022-07-29

2. Relationship between serum vascular cell adhesion molecule-1 and endothelin-1 levels with organ involvement and disease activity in systemic lupus erythematosus patients;Lupus;2018-08-29

3. Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot Study;BioMed Research International;2018

4. Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease;Rheumatology;2015-07-31

5. A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis;PLOS ONE;2015-05-08